Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M B Maeng"'
Publikováno v:
European Heart Journal. 43
Background The European Society of Cardiology recommends addition of a second antithrombotic drug (a P2Y12 inhibitor or rivaroxaban 2.5 mg twice daily) on top of aspirin in selected patients with chronic coronary syndrome (CCS) at high residual risk